Vassos Neocleous
Overview
Explore the profile of Vassos Neocleous including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
54
Citations
446
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Fanis P, Morrou M, Tomazou M, Alghol H, Spyrou G, Neocleous V, et al.
Mol Cell Endocrinol
. 2025 Jan;
598:112468.
PMID: 39842623
Background And Aims: Puberty is a crucial developmental stage marked by the transition from childhood to adulthood, organized by complex hormonal signaling within the neuroendocrine system. The hypothalamus, a central...
2.
Neocleous V, Fanis P, Toumba M, Skordis N, Phylactou L
Orphanet J Rare Dis
. 2024 Apr;
19(1):167.
PMID: 38637882
The report covers the current and past activities of the department Molecular Genetics-Function and Therapy (MGFT) at the Cyprus Institute of Neurology and Genetics (CING), an affiliated Reference Center for...
3.
Fanis P, Neocleous V, Papapetrou I, Phylactou L, Skordis N
Int J Mol Sci
. 2023 Nov;
24(21).
PMID: 37958948
Human sexual and reproductive development is regulated by the hypothalamic-pituitary-gonadal (HPG) axis, which is primarily controlled by the gonadotropin-releasing hormone (GnRH) acting on its receptor (GnRHR). Dysregulation of the axis...
4.
Neocleous V, Fanis P, Frangos S, Skordis N, Phylactou L
Life (Basel)
. 2023 Jun;
13(6).
PMID: 37374115
Multiple endocrine neoplasia type 2 (MEN2) is an autosomal dominant (AD) condition with very high penetrance and expressivity. It is characterized into three clinical entities recognized as MEN2A, MEN2B, and...
5.
Fanis P, Skordis N, Toumba M, Picolos M, Tanteles G, Neocleous V, et al.
Front Endocrinol (Lausanne)
. 2023 Jun;
14:1156616.
PMID: 37324257
Objective: The study aimed to identify the pathogenic status of p.Gln319Ter (NM_000500.7: c.955C>T) variant when inherited in a single gene (bimodular RCCX haplotype) and to discriminate between a non-causing congenital...
6.
Holm Johannsen T, Albrethsen J, Neocleous V, Baronio F, Cools M, Aksglaede L, et al.
Endocr Connect
. 2023 May;
12(8).
PMID: 37256668
Congenital adrenal hyperplasia (CAH) is a recessive condition that affects the adrenal glands. Despite life-long replacement therapy with glucocorticoids and mineralocorticoids, adult patients with CAH often experience impaired gonadal function....
7.
Fanis P, Morrou M, Tomazou M, Michailidou K, Spyrou G, Toumba M, et al.
Front Endocrinol (Lausanne)
. 2023 Jan;
13:1075341.
PMID: 36714607
Makorin RING finger protein 3 (MKRN3) is an important factor located on chromosome 15 in the imprinting region associated with Prader-Willi syndrome. Imprinted is expressed in hypothalamic regions essential for...
8.
Constantinou M, Lampi M, Parperis K, Neocleous V, Fanis P, Phylactou L, et al.
Rheumatology (Oxford)
. 2023 Jan;
62(8):e249-e250.
PMID: 36688693
No abstract available.
9.
Fanis P, Skordis N, Phylactou L, Neocleous V
Hormones (Athens)
. 2022 Oct;
22(1):71-77.
PMID: 36264454
Background: Genetic diversity of mutations in the CYP21A2 gene is the main cause of the monogenic congenital adrenal hyperplasia (CAH) disorder. On chromosome 6p21.3, the CYP21A2 gene is partially overlapped...
10.
Nowotny H, Neumann U, Tardy-Guidollet V, Ahmed S, Baronio F, Battelino T, et al.
Eur J Endocrinol
. 2022 Mar;
186(5):K17-K24.
PMID: 35235536
Objective: To assess the current medical practice in Europe regarding prenatal dexamethasone (Pdex) treatment of congenital adrenal hyperplasia (CAH) due to 21-hydroxylase deficiency. Design And Methods: A questionnaire was designed...